Predictors of long-term employment among patients with cystic fibrosis undergoing lung transplantation

Pulmonary Fibrosis

Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation

J Cyst Fibros.

Kapnadak SG, Kicska GA, Ramos KJ, Marshall DA, Carroll TY, Pipavath SN, Mulligan MS, Goss CH, Aitken ML

doi: 10.1016/j.jcf.2017.07.015.

Lung Cancer

Lung transplant recipients on long-term extracorporeal photopheresis

Clin Transplant.

Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C

doi: 10.1111/ctr.13041.

RECOMMENDED

Pulmonary Fibrosis

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Cyst Fibros.

Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L

doi: 10.1016/j.jcf.2020.07.022.

COMMENTED

Pulmonary Fibrosis

Lung transplantation for cystic fibrosis

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

doi: 10.1016/j.healun.2020.02.010.

RECOMMENDED

Bronchi

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

Lancet Respir Med.

Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE

doi: 10.1016/S2213-2600(18)30427-2.

RECOMMENDED

Pulmonary Fibrosis

Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

★ 2 Recommended by Dr Martin Frey, Faculty Member

doi: 10.1002/ppul.24747.

CoughPulmonary Fibrosis

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.

Lancet Respir Med.

Konstan MW, McKone EF, Moss RB, Marigowda G, Tian S, Waltz D, Huang X, Lubarsky B, Rubin J, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan W, Sawicki GS.

doi: 10.1016/

Pulmonary Fibrosis

Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study

Curr Med Res Opin.

Sommerwerck U, Virella-Lowell I, Angyalosi G, Viegas A, Cao W, Debonnett L

doi: 10.1080/

RECOMMENDED

Pulmonary Fibrosis

UNDERWEIGHT PATIENTS WITH CYSTIC FIBROSIS HAVE ACCEPTABLE SURVIVAL AFTER LUNG TRANSPLANTATION: A UNOS REGISTRY STUDY

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Chest.

Ramos KJ, Kapnadak SG, Bradford MC, Somayaji R, Morrell ED, Pilewski JM, Lease ED, Mulligan MS, Aitken ML, Gries CJ, Goss CH

doi: 10.1016/j.chest.2019.11.043.

Related content

Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation

Lung transplant recipients on long-term extracorporeal photopheresis

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

Lung transplantation for cystic fibrosis

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.

Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study

UNDERWEIGHT PATIENTS WITH CYSTIC FIBROSIS HAVE ACCEPTABLE SURVIVAL AFTER LUNG TRANSPLANTATION: A UNOS REGISTRY STUDY